Drug Type siRNA |
Synonyms SGB 3403 |
Target |
Mechanism PCSK9 modulators(Proprotein convertase subtilisin kexin type 9 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Phase 1 | CN | 20 Feb 2024 | |
Heterozygous familial hypercholesterolemia | Phase 1 | CN | 20 Feb 2024 | |
Hyperlipidemias | Phase 1 | - | 18 Feb 2024 | |
Hypercholesterolemia | Phase 1 | AU | 31 May 2023 | |
Atherosclerotic occlusive disease | IND Approval | CN | 07 Oct 2023 |